Related Experiment Video
Updated: May 16, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Endocardial and myocardial involvement in systemic sclerosis--is there a relevant inflammatory component?
Robert Dinser1, Marc Frerix, Florian M P Meier
1Department of Internal Medicine and Rheumatology, Justus-Liebig-University of Giessen, Kerckhoff-Klinik, Rheumatology and Clinical Immunology, Benekestr 2-8, 61231 Bad Nauheim, Germany.
Systemic sclerosis can cause heart inflammation, not just fibrosis. Early diagnosis and treatment with medications like cyclophosphamide and rituximab may stabilize cardiac function in patients with systemic sclerosis.
Area of Science:
- Cardiology
- Rheumatology
- Immunology
Background:
- Systemic sclerosis commonly causes cardiac disease, primarily attributed to myocardial fibrosis.
- The role of inflammation in the cardiac manifestations of systemic sclerosis is not fully understood.
Observation:
- Two cases of newly diagnosed systemic sclerosis with cardiac involvement are presented.
- Case 1 showed tricuspid failure and myocardial inflammation confirmed by biopsy and MRI, responding to cyclophosphamide.
- Case 2 exhibited renal crisis, pulmonary alveolitis, and myocardial inflammation, with improvement after rituximab addition.
Findings:
- Endocardial and myocardial inflammation can be significant components of cardiac disease in systemic sclerosis.
- Treatment with immunosuppressants (cyclophosphamide, rituximab) showed potential in managing cardiac inflammation and function.
Implications:
- These findings suggest that inflammatory processes may play a more crucial role in systemic sclerosis-related heart disease than previously recognized.
- Further research is warranted to explore the prevalence and impact of cardiac inflammation in systemic sclerosis and optimize therapeutic strategies.
Related Concept Videos
Myocarditis I: Introduction
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Endocarditis II: Clinical Features of Infective Endocarditis
Myocarditis II: Clinical Features and Diagnostic Tests
Cardiomyopathy IV: Restrictive Cardiomyopathy
